Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Keytruda

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Keytruda was produced by Merck & Co..

Merck & Co to buy IO specialists Immune Design for $300m

Merck & Co to buy IO specialists Immune Design for $300m The move is aimed at helping the pharma giant consolidate its dominance in the field of immunotherapy (IO), where its checkpoint inhibitor Keytruda leads with annual sales of $7bn in 2018.

2019: CRISPR and therapeutic gene editing comes of age

2019: CRISPR and therapeutic gene editing comes of age The cells were gene-edited to lack PD-1, the immune checkpoint targeted by drugs such as Merck &Co’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Opdivo (nivolumab), and the

Merck puts prostate cancer firmly in Keytruda’s sights

Merck puts prostate cancer firmly in Keytruda’s sights In the Keytruda plus Lynparza arm, 12% of patients had a 50% or greater reduction in PSA, a biomarker which is elevated in prostate cancer. ... Meanwhile, the chemotherapy combination had a PSA response rate of 31%, while for the Keytruda/Xtandi group it

Immuno-oncology in 2019: the rapid evolution continues

Immuno-oncology in 2019: the rapid evolution continues PD-1/PD-L1 inhibitors: Keytruda is King, but the market is developing fast. ... On 28 December, Keytruda gained FDA clearance for use in Merkel cell carcinoma.

Keytruda combo outshines Opdivo in kidney cancer

Keytruda combo outshines Opdivo in kidney cancer Kidney cancer is one of the few therapy areas where BMS has had the upper hand on Merck &Co’s Keytruda, but new data on its use in combination with ... However the huge momentum and weight of data behind Keytruda makes its expansion into this field a

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics